The Medicines Company (MDCO) vs. Hedge Fund Favorites in 2019
Hedge funds and other investment firms that we track manage billions of dollars of their wealthy clients' money, and needless to say, they are painstakingly thorough when analyzing...
Posts Tagged ‘NASDAQ:MDCO’
Hedge Funds Hit The Bullseye With This Stock Pick
After several tireless days we have finished crunching the numbers from nearly 750 13F filings issued by the elite hedge funds and other investment firms that we track at Insider...
Hedge Funds Have Never Been This Bullish On The Medicines Company (MDCO)
We are still in an overall bull market and many stocks that smart money investors were piling into surged through October 17th.
Did Hedge Funds Drop The Ball On Medicines Company (MDCO)?
Hedge funds run by legendary names like George Soros and David Tepper make billions of dollars a year for themselves and their super-rich accredited investors (you’ve got to...
Hedge Fund and Insider Trading News: The Children’s Investment Fund, JDP Capital Management, Standard Motor Products, Inc. (SMP), Chembio Diagnostics Inc (CEMI), and More
The majority of investors in The Children’s Investment Fund (TCI), the British hedge fund run by Sir Christopher Hohn, have shunned a chance to redeem money after up to $1...
Did Hedge Funds Drop The Ball On The Medicines Company (MDCO) ?
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great...
Hedge Fund and Insider Trading News: Eddie Lampert, Starboard Value LP, Elliott Management, Hartford Financial Services Group (HIG), The Medicines Company (MDCO), and More
For a company owner, a clean sale is usually preferable to the rigmarole of going public.
Hedge Fund and Insider Trading News: David Tepper, GMT Capital, Cosmos Holdings Inc (COSM), Strongbridge Biopharma PLC (SBBP), Sequential Brands Group Inc (SQBG), and More
Hedge fund manager David Tepper said Monday he is buying some stocks after the markets had their worst week in a decade.
Is The Medicines Company (MDCO) A Good Stock To Buy?
A market correction in the fourth quarter, spurred by a number of global macroeconomic concerns and rising interest rates ended up having a negative impact on the markets and ...
Hedge Fund and Insider Trading News: Jonathan Litt, Mike Novogratz, The Medicines Company (MDCO), Checkpoint Therapeutics Inc (CKPT), Koppers Holdings Inc. (KOP), and More
Nov 28 (Reuters) - Activist investor Jonathan Litt on Wednesday renewed call for the sale of the Saks Fifth Avenue brand, while asking owner Hudson’s Bay Co to make new board...
Sarissa Capital’s Alex Denner Bullish on Biogen (BIIB)
Sarissa Capital Management is a Greenwich, Connecticut-based activist hedge fund established in 2012 by its current chief investment officer, Dr.
Market Movers Today: Tenax Therapeutics Inc (TENX), Overstock.com Inc (OSTK), Box Inc (BOX), Patterson Companies, Inc. (PDCO), and More
Tenax Therapeutics Inc shares surged 140.5 percent to $ 11.16 as the company reported the publication of preclinical data showing added evidence of levosimendan treatment effects...
This Fund’s Picks Gained 200% In A Year And Why No One Knows About It
You probably haven't heard of Alex Denner's Sarissa Capital Management, which is a shame, as the fund is coming off a first-quarter in which its stock picks in companies valued...
13G Filing: Partner Fund Management and Medicines Co (MDCO)
You can access the original SEC filing by clicking here.
Amgen, Esperion, AmTrust Financial and More: What is Going On With These Falling Stocks?
Although all three major indexes have rebounded into the green this afternoon, shares of five companies, Amgen, Inc.
Hedge Funds Are Betting On The Medicines Company (MDCO)
Legendary investors such as Leon Cooperman and Seth Klarman earn enormous amounts of money for themselves and their investors by doing in-depth research on small-cap stocks that...
Movers In Biotech: Cellectar Biosciences Inc (CLRB) And The Medicines Company (MDCO)
We’ve had another big day in biotech, and a number of companies have moved on news and fundamental developments.
Biogen (BIIB) Helped Healthcare Funds Like This One Dominate The Third Quarter
The majority of hedge funds and other top money managers tend to have a long-term focus when they make investments.
Decsontructing The Latest The Medicines Company (MDCO) Release
The Medicines Company (NASDAQ:MDCO) just put out topline from its lead cholesterol trial, and the company has jumped on the back of the data.
Why Yum, Booz Allen Hamilton, Alnylam, and More Are in the Spotlight
Many traders are watching crude futures today to see if WTI can break out of the $50 per barrel mark.
Gartner Inc. (IT), Signet Jewelers (SIG), and WPX Energy (WPG) Among the Companies Reporting Notable Insider Trading Activity
While Securities and Exchange Commission rules require executives, directors and other insiders to report purchases or sales in their own company’s stock within two days, an...
Is The Medicines Company (MDCO) A Good Stock To Buy?
Like everyone else, elite investors make mistakes.
The Medicines Company (MDCO) and Alnylam Pharmaceuticals Inc. (ALNY)’s Positive Phase I Results Support Hedge Funds’ Confidence in These Companies
On August 30, The Medicines Company (NASDAQ:MDCO) and Alnylam Pharmaceuticals Inc.
Healthcare-Focused Fund Camber Capital’s Top Picks: Masimo Corporation (MASI), The Medicines Company (MDCO)
Camber Capital Management is a hedge fund headquartered in Boston and founded by Stephen DuBois.
TrovaGene Inc (TROV) Sees Bridger Management Buy More Shares; Other Stocks Roberto Mignone Loves
Roberto Mignone's Bridger Management is a fund with around $2.0 billion in assets, one that is focused on healthcare stocks, which represent nearly one-half of the fund's equity...
The Medicines Company (MDCO), TG Therapeutics Inc (TGTX): Bridger Management & Ra Capital Management Taking Plunge
In the last few days, we have seen a lot of capital from funds that we track getting shifted to pharmaceutical stocks and no it’s not just sector specific funds, but funds across...
Point State Capital Boosts its Stake in The Medicines Company (MDCO) to 7%
Led by Sean Cullinan, Point State Capital revealed a significantly increased position in The Medicines Company (NASDAQ:MDCO).
Hedge Funds Are Betting On United Therapeutics Corporation (UTHR)
If you were to ask many traders, hedge funds are viewed as useless, outdated financial tools of a forgotten age.
The Medicines Company (MDCO), United Therapeutics Corporation (UTHR): Hedge Fund and Insider Sentiment Unchanged, What Should You Do?
In the eyes of many investors, hedge funds are perceived as bloated, outdated financial vehicles of a forgotten age.
Cubist Pharmaceuticals Inc (CBST): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?
If you were to ask many of your fellow readers, hedge funds are assumed to be overrated, outdated financial tools of an era lost to time.
Hedge Funds Aren’t Crazy About Amarin Corporation plc (ADR) (AMRN) Anymore
In the financial world, there are many metrics shareholders can use to track their holdings. A duo of the most innovative are hedge fund and insider trading movement.
The Medicines Company (MDCO), Merck & Co., Inc. (MRK), Baxter International Inc. (BAX): Three Reasons to Like This Critical Care Company
The Medicines Company (NASDAQ:MDCO) is a mid-cap value stock that jumped by 21% in the last 12 months, trading at a 52-week price range of $20.04-$37.40.
The Medicines Company (MDCO), AstraZeneca plc (ADR) (AZN): A Small-Cap Pharmaceutical Company With 2014 in Its Sights
A few months back, Barron's featured an intriguing pharmaceutical company that goes by the name The Medicines Company (NASDAQ:MDCO).
Taro Pharmaceutical Industries Ltd. (TARO): Insiders Aren’t Crazy About It
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) was in 8 hedge funds' portfolio at the end of March.
Pipeline Probe: Alnylam Pharmaceuticals, Inc. (ALNY)
Shares of biotech Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) have soared over 160% in the past year.
Is United Therapeutics Corporation (UTHR) Going to Burn These Hedge Funds?
If you'd ask most investors, hedge funds are perceived as slow, old investment tools of the past.
Should You Buy The Medicines Company (MDCO)?
At the moment, there are a multitude of metrics investors can use to analyze their holdings. A duo of the most under-the-radar are hedge fund and insider trading activity.
Amarin Corporation plc (ADR) (AMRN): What’s The Smart Money Think?
Amarin Corporation plc (ADR) (NASDAQ:AMRN) was in 19 hedge funds' portfolio at the end of March.
The Medicines Company (MDCO): Is There a Future for Small Pharma?
Small pharma is fighting an uphill battle. Fortunately, this is precisely what inspires a lot of companies to reach for the heavens.
Hedge Funds Are Crazy About The Medicines Company (NASDAQ:MDCO)
According to most traders, hedge funds are seen as unimportant, outdated investment tools of years past.
3 Earning Results that Could Lead to a Long-Term Trend Higher: The Home Depot, Inc. (HD) and More
Earnings and earning-related news is the number one catalyst for stock movement.
